The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Global reporting of progress towards elimination of hepatitis B and hepatitis C
Open accessAbstract
BACKGROUND: The 69th World Health Assembly endorsed the global health sector strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030. Achieving and measuring the 2030 targets requires a substantial increase in the capacity to test and treat viral hepatitis infections and a mechanism to monitor the progress of hepatitis elimination. This study aimed to identify the gaps in data availability or quality and create a new mechanism to monitor the progress of hepatitis elimination. METHODS: In 2020, using a questionnaire, we collected empirical, systematic, modelled, or surveyed data-reported by WHO country and WHO regional offices-on indicators of progress towards elimination of viral hepatitis, including burden of infection, incidence, mortality, and the cascade of care, and validated these data. FINDINGS: WHO received officially validated country-provided data from 130 countries or territories, and used partner-provided data for 70 countries or territories. We estimated that in 2019, globally, 295·9 million (3·8%) people were living with chronic hepatitis B virus (HBV) infection and 57·8 million (0·8%) people were living with chronic hepatitis C virus (HCV) infection. Globally, there were more than 3·0 million new infections with HBV and HCV and more than 1·1 million deaths due to the viruses in 2019. In 2019, 30·4 million (95% CI 24·3-38·0) individuals living with hepatitis B knew their infection status and 6·6 million (5·3-8·3) people diagnosed with hepatitis B received treatment. Among people with HCV infection, 15·2 million (95% CI 12·1-19·0) had been diagnosed between 2015 and 2019, and 9·4 million (7·5-11·7) people diagnosed with hepatitis C infection were treated with direct-acting antiviral drugs between 2015 and 2019. INTERPRETATION: There has been notable global progress towards hepatitis elimination. In 2019, 30·4 million (10·3%) people living with hepatitis B knew their infection status, which was slightly higher than in 2015 (22·0 million; 9·0%), and 6·6 million (22·7%) of those diagnosed with hepatitis B received treatment, compared with 1·7 million (8·0%) in 2015. Mortality from hepatitis C has declined since 2019, driven by an increase in HCV treatment ten times that of the strategy baseline. However, an estimated 89·7% of HBV infections and 78·6% of HCV infections remain undiagnosed. A new global strategy for 2022-30, based on these new estimates, should be implemented urgently to scale up the screening and treatment of viral hepatitis. FUNDING: World Health Organization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.-S., Muljono, D. H., Waked, I., Alavian, S. M., Lee, M.-H., Negro, F., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30181-9 · Cited by 2,006
Self-citationRazavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30056-6 · Cited by 1,661
Self-citationNachega, J. B., Uthman, O. A., Anderson, J., Peltzer, K., Wampold, S., Cotton, M. F., Mills, E. J., Ho, Y.-S., Stringer, J. S. A., McIntyre, J. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328359590f · Cited by 488
Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32657-x · Cited by 300
Self-citationScreening and Treatment Program to Eliminate Hepatitis C in Egypt
Waked, I., Esmat, G., Elsharkawy, A., El-Serafy, M., Abdel-Razek, W., Ghalab, R., Elshishiney, G., Salah, A., Abdel Megid, S., Kabil, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr1912628 · Cited by 282
Oru, E., Trickey, A., Shirali, R., Kanters, S., & Easterbrook, P. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30505-2 · Cited by 200
Self-citationProgress towards elimination goals for viral hepatitis
Cox, A. L., El-Sayed, M. H., Kao, J.-H., Lazarus, J. V., Lemoine, M., Lok, A. S., & Zoulim, F. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0332-6 · Cited by 198
Geue, C., Wu, O., Xin, Y., Heggie, R., Hutchinson, S. J., Martin, N. K., Fenwick, E. A. L., & Goldberg, D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145022 · Cited by 36
Machmud, P. B., Glasauer, S., Gottschick, C., & Mikolajczyk, R. (2021) · Vaccines · doi:10.3390/vaccines9060625 · Cited by 32
Ali, S., Ur-Rehman, T., Ali, M., et al. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-01202-1 · Cited by 11
Cited by
The Global Burden of Liver Disease
Younossi, Z. M., Wong, G., Anstee, Q. M., & Henry, L. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.015 · Cited by 500
Metadata
- Authors
- Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., Doherty, M., Luhmann, N., Easterbrook, P., Dirac, M., de Martel, C., Nayagam, S., Hallett, T. B., Vickerman, P., Razavi, H., Lesi, O., & Low-beer, D.
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 8
- Issue
- 4
- Pages
- 332-342
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- OpenAlex
- W4319336161
- Cited by
- 327
- References
- 10
- FWCI
- 54.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global reporting of progress towards elimination of hepatitis B and hepatitis C. https://app.cochat.ai/papers/10.1016/s2468-1253(22)00386-7
- The paper
- Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., Doherty, M., Luhmann, N., Easterbrook, P., Dirac, M., de Martel, C., Nayagam, S., Hallett, T. B., Vickerman, P., Razavi, H., . . . Low-beer, D. (2023). Global reporting of progress towards elimination of hepatitis B and hepatitis C. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(22)00386-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.